FS

Friedrich Scheiflinger

BI Baxter International: 28 patents #27 of 2,334Top 2%
BS Baxter Healthcare Sa: 27 patents #14 of 1,132Top 2%
BI Baxalta Incorporated: 23 patents #4 of 230Top 2%
TL Takeda Pharmaceutical Company Limited: 10 patents #147 of 1,531Top 10%
BA Baxter Aktiengesellschaft: 4 patents #14 of 86Top 20%
SB Stichting Sanquin Bloedvoorziening: 4 patents #5 of 43Top 15%
NT Nektar Therapeutics: 3 patents #79 of 250Top 35%
IA Immuno Aktiengesellschaft: 3 patents #18 of 75Top 25%
BG Baxter Innovations Gmbh: 3 patents #7 of 22Top 35%
CC Children'S Medical Center: 2 patents #340 of 1,211Top 30%
DY Dyax: 1 patents #88 of 129Top 70%
Overall (All Time): #25,010 of 4,157,543Top 1%
76
Patents All Time

Issued Patents All Time

Showing 1–25 of 76 patents

Patent #TitleCo-InventorsDate
11793855 TFPI inhibitors and methods of use Michael Dockal, Rudolf Hartmann, Markus Fries, Hartmut Ehrlich, Ulrich Reineke +2 more 2023-10-24
11707536 Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A Hanspeter Rottensteiner 2023-07-25
11596671 Gene therapy of hemophilia B using viral vectors encoding recombinant fix variants with increased expression Hanspeter Rottensteiner, Franziska Horling, Johannes Lengler 2023-03-07
11492388 Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A Falko-Günter Falkner, Franziska Horling, Johannes Lengler, Hanspeter Rottensteiner 2022-11-08
11402388 Anti-MIF immunohistochemistry Michael Thiele, Randolf Kerschbaumer, Dirk Voelkel, Patrice Douillard, Alexander SCHINAGL 2022-08-02
11254731 Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A Falko-Günter Falkner, Franziska Horling, Johannes Lengler, Hanspeter Rottensteiner 2022-02-22
11191818 Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome Bruce Ewenstein, Brahm Goldstein, Bernhard Majer, Paolo ROSSATO, Marietta Turecek 2021-12-07
11160850 Compositions of human prothrombin and activated factor X for improving hemostasis in the treatment of bleeding disorders Michael Dockal, Sabine Knappe, Susanne Till, Peter Turecek 2021-11-02
11124787 ADAMTS13-containing compositions having thrombolytic activity Denisa D. Wagner, Anil Chauhan, Barbara Plaimauer 2021-09-21
11001613 TFPI inhibitors and methods of use Michael Dockal, Hartmut Ehrlich, Ulf Reimer, Ulrich Reineke, Thomas Polakowski +1 more 2021-05-11
10842853 Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia B Franziska Horling, Johannes Lengler, Falko-Günter Falkner, Hanspeter Rottensteiner 2020-11-24
10822376 Biologically active peptides Michael Dockal 2020-11-03
10800816 TFPI inhibitors and methods of use Michael Dockal, Rudolf Hartmann, Frank Osterkamp, Thomas Polakowski, Ulrich Reineke 2020-10-13
10287319 Biologically active peptides Michael Dockal 2019-05-14
10251941 Factor VIIa-polysialic acid conjugates having prolonged in vivo half-life Peter Turecek, Juergen Siekmann, Michel Canavaggio 2019-04-09
10233436 ADAMTS13-containing compositions having thrombolytic activity Denisa D. Wagner, Anil Chauhan, Barbara Plaimauer 2019-03-19
10201586 TFPI inhibitors and methods of use Michael Dockal, Rudolf Hartmann, Markus Fries, Hartmut Ehrlich, Ulrich Reineke +2 more 2019-02-12
10189889 Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A Falko-Günter Falkner, Franziska Horling, Johannes Lengler, Hanspeter Rottensteiner 2019-01-29
10189888 Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A Falko-Günter Falkner, Franziska Horling, Johannes Lengler, Hanspeter Rottensteiner 2019-01-29
10124033 Peptides and methods of use Michael Dockal, Thomas Polakowski, Frank Osterkamp, Rudolf Hartmann, Matthias Paschke +1 more 2018-11-13
9958456 OxMIF as a diagnostic marker Michael Thiele, Randolf Kerschbaumer, Dirk Voelkel, Patrice Douillard 2018-05-01
9873720 TFPI inhibitors and methods of use Michael Dockal, Rudolf Hartmann, Frank Osterkamp, Thomas Polakowski, Ulrich Reineke 2018-01-23
9777051 TFPI inhibitors and methods of use Michael Dockal, Hartmut Ehrlich, Ulf Reimer, Ulrich Reineke, Thomas Polakowski +1 more 2017-10-03
9617523 Nucleic acids encoding vitamin K expoxide reductase subunit 1 and vitamin K dependent protein expression and methods of using same Ernst Boehm 2017-04-11
9598464 Biologically active peptides Michael Dockal 2017-03-21